Acetyl Salicylic acid

PreclinicalSmall molecule

Astellas

Indications

Total Trials

Active Trials

Competitors

Timeline

Expected Milestones

Q4 2030

Phase 3Not yet recruiting

Giant Cell Arteritis (GCA)

NCT07908082

Clinical

Trials by Indication[1]

Platelet Function2 trials

Pharmacodynamic-pharmacokinetic Trial, of Slow Release ASA, in the Platelet Functionalism.

Completed·RRottapharm Spain·Phase 1·NCT00425074·50 enrolled

Pharmacodynamic Trial, of Slow Release ASA, in Platelet Functionalism, a Long Term Treatment Period

Completed·RRottapharm Spain·Phase 2/3·NCT00501254·100 enrolled

Inflammation1 trial

Aggravated Airway Inflammation: Research on Genomics and Optimal Medical Care (AirGOs-medical)

Completed·SSanna Salmi·N/A·NCT03825757·40 enrolled

Intracytoplasmic Sperm Injection1 trial

The Value of Prednisolone With Aspirin Before Embryo Transfer in Intracytoplasmic Sperm Injection (ICSI) Cycles

Completed·KKasr El Aini Hospital·Phase 2/3·NCT03503227·250 enrolled

Clopidogrel1 trial

To Evaluate Whether Acetyl Salicylic Acid (Aspirin), the Combination of Aspirin and Clopidogrel and Darexaban (YM150) Interact in Their Effects

Completed· Astellas logo

Astellas·Phase 1·NCT01409616·100 enrolled

Tics1 trial

Comparison of Pharmacokinetics of Dipyridamole in Asasantin Extended Release (ER) and in a Combination of Persantin Immediate Release Tablets and ASA Tablets in Healthy Subjects

Completed· Boehringer Ingelheim logo

Boehringer Ingelheim·Phase 1·NCT02273505·20 enrolled

3 more indications

Aspirin1 trial

To Evaluate Whether Acetyl Salicylic Acid (Aspirin) and Darexaban (YM150) Interact in Their Effects

Completed· Astellas logo

Astellas·Phase 1·NCT01424332·24 enrolled

Effectiveness1 trial

Cost Effectiveness Analysis In Patients With Heart Valve Prosthesis

Unknown status·PPharmacoeconomic Unit, Egypt·Phase 4·NCT02022527·300 enrolled

Giant Cell Arteritis (GCA)1 trial

Aspirin for the Prevention of Ischemic-Related Events in Giant Cell Arteritis Pilot (ASPIRE-GCA Pilot)

Not yet recruiting·CCentre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal·Phase 3·NCT07908082·120 enrolled

Sources

References

[1]
ClinicalTrials.gov — 9 trial records for Acetyl Salicylic acid. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Acetyl Salicylic acid compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Acetyl Salicylic acid. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Astellas company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: Astellas